Balance Sheet: Liabilities and Stockholders’ Equity
Quarterly Data
The balance sheet provides creditors, investors, and analysts with information on company resources (assets) and its sources of capital (its equity and liabilities). It normally also provides information about the future earnings capacity of a company assets as well as an indication of cash flows that may come from receivables and inventories.
Liabilities represents obligations of a company arising from past events, the settlement of which is expected to result in an outflow of economic benefits from the entity.
Paying user area
Try for free
Vertex Pharmaceuticals Inc. pages available for free this week:
- Balance Sheet: Assets
- Common-Size Balance Sheet: Assets
- Enterprise Value (EV)
- Enterprise Value to EBITDA (EV/EBITDA)
- Capital Asset Pricing Model (CAPM)
- Selected Financial Data since 2005
- Return on Equity (ROE) since 2005
- Return on Assets (ROA) since 2005
- Total Asset Turnover since 2005
- Aggregate Accruals
The data is hidden behind: . Unhide it.
Get full access to the entire website from $10.42/mo, or
get 1-month access to Vertex Pharmaceuticals Inc. for $24.99.
This is a one-time payment. There is no automatic renewal.
We accept:
Vertex Pharmaceuticals Inc., consolidated balance sheet: liabilities and stockholders’ equity (quarterly data)
US$ in thousands
Based on: 10-Q (reporting date: 2025-06-30), 10-Q (reporting date: 2025-03-31), 10-K (reporting date: 2024-12-31), 10-Q (reporting date: 2024-09-30), 10-Q (reporting date: 2024-06-30), 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31).
The quarterly financial data exhibits notable variations and trends in liabilities and shareholders’ equity over the observed periods.
- Current Liabilities
-
Accounts payable shows fluctuations, with a marked increase around the end of 2021 and continuing elevated levels through 2025, indicating rising obligations to suppliers.
Accrued expenses generally trend upward with significant rises in mid-2022 and subsequent quarters, suggesting increasing expenses incurred but not yet paid.
Other current liabilities exhibit volatility, peaking significantly in late 2023 before declining and then rising again in 2025, reflecting inconsistency in short-term obligations.
Overall, current liabilities increased steadily from approximately 1.54 billion US$ in early 2020 to over 4.1 billion US$ by mid-2025, reflecting growth in short-term financial obligations.
- Long-Term Liabilities
-
Long-term operating lease liabilities are missing in early 2020 but then appear and show moderate fluctuations around 350 million US$ to 380 million US$. Toward 2024 and beyond, these liabilities increase sharply above 1.5 billion US$, indicating heightened long-term lease commitments.
Other long-term liabilities display a slight downward trend from early 2020 through late 2022, followed by a recovery and increase by mid-2025, suggesting variable long-term debt or obligations.
Total long-term liabilities increase from 0.89 billion US$ in early 2020 to nearly 2.7 billion US$ by mid-2025, with pronounced growth in the later periods primarily driven by lease liabilities.
- Total Liabilities
-
Total liabilities steadily increase from approximately 2.4 billion US$ in March 2020 to nearly 6.9 billion US$ by the end of 2024. Despite some fluctuations, the overall trend indicates expanding financial obligations, both current and long-term.
- Shareholders’ Equity
-
Common stock remains relatively stable at around 2.6 million US$, reflecting little change in share capital.
Additional paid-in capital shows an irregular trend, rising and falling over the years, with a peak around 7.4 billion US$ in late 2023 followed by a decline toward mid-2025, indicating variable equity financing activities or adjustments.
Accumulated other comprehensive income (loss) demonstrates significant volatility, fluctuating between positive and negative values, including large negative swings in early 2021 and early 2025, which may reflect changes in foreign currency translation or other comprehensive income items.
Retained earnings show strong growth, increasing from a deficit of approximately -1.25 billion US$ in early 2020 to a positive 11.3 billion US$ by mid-2025, highlighting consistent profitability or accumulated earnings over the period.
Overall shareholders’ equity rises from roughly 6.5 billion US$ in early 2020 to over 17 billion US$ by mid-2025, driven mainly by increasing retained earnings and, to a lesser extent, paid-in capital.
- Total Liabilities and Shareholders’ Equity
-
The sum of liabilities and shareholders’ equity grows from about 8.9 billion US$ in early 2020 to approximately 24 billion US$ by mid-2025, indicating substantial growth in the company's financial size and resources over the period.
In summary, the data reveals significant expansion in both liabilities and equity, with current liabilities and retained earnings showing strong upward trends. Long-term lease obligations have surged markedly in recent periods, potentially reflecting changes in lease accounting or new commitments. The volatility in comprehensive income items and paid-in capital suggests episodic events affecting equity components. Overall, the financial position reflects growth and increasing complexity in the company's obligations and equity structure.